UK markets open in 16 minutes

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
51.54-1.27 (-2.40%)
At close: 04:00PM EDT
51.37 -0.17 (-0.33%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
13,400,000
12,682,000
11,888,000
9,913,000
10,735,000
Cost of revenue
4,135,000
4,003,000
3,760,000
3,510,000
3,181,000
Gross profit
9,265,000
8,679,000
8,128,000
6,403,000
7,554,000
Operating expenses
Research development
1,364,000
1,323,000
1,204,000
1,143,000
1,174,000
Selling general and administrative
4,865,000
4,520,000
4,359,000
3,787,000
3,941,000
Total operating expenses
7,042,000
6,646,000
6,304,000
5,719,000
5,814,000
Operating income or loss
2,223,000
2,033,000
1,824,000
684,000
1,740,000
Interest expense
262,000
470,000
341,000
361,000
473,000
Total other income/expenses net
-462,000
-424,000
-408,000
-459,000
-581,000
Income before tax
1,510,000
1,141,000
1,076,000
-138,000
687,000
Income tax expense
599,000
443,000
36,000
2,000
-4,013,000
Income from continuing operations
912,000
698,000
1,041,000
-140,000
4,700,000
Net income
912,000
698,000
1,041,000
-140,000
4,700,000
Net income available to common shareholders
861,000
642,000
985,000
-173,000
4,700,000
Basic EPS
-
0.45
0.69
-0.08
3.38
Diluted EPS
-
0.45
0.69
-0.08
3.33
Basic average shares
-
1,430,500
1,422,300
1,416,700
1,391,500
Diluted average shares
-
1,439,700
1,433,800
1,416,700
1,410,600